Vimarsana
Biggest News Aggregation in the World

Page 26 - Multiple Sclerosis Centers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multiple Sclerosis Centers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multiple Sclerosis Centers Today - Breaking & Trending Today

Antipsychotic Effective for Steroid-Induced Psychosis in MS - Vimarsana News

Antipsychotic Effective for Steroid-Induced Psychosis in MS

A popular antipsychotic calms patients with multiple sclerosis (MS) who develop psychiatric distress after taking corticosteroids, a new case review suggests.

Eculizumab Lowers Relapse Risk in Neuromyelitis Optica Spectrum Disorder After Prior Rituximab Treatment - Vimarsana News

Eculizumab Lowers Relapse Risk in Neuromyelitis Optica Spectrum Disorder After Prior Rituximab Treatment

Eculizumab is associated with a lower relapse risk and low infection rates in patients with neuromyelitis optical spectrum previously treated with rituximab.

Ponesimod vs Teriflunomide for Multiple Sclerosis-Related Fatigue - Vimarsana News

Ponesimod vs Teriflunomide for Multiple Sclerosis-Related Fatigue

Ponesimod provides clinical benefit over teriflunomide for fatigue among patients with relapsing multiple sclerosis regardless of disease activity status.

The Effect of Physical Activity on Perceived Fatigue in Relapsing-Remitting MS - Vimarsana News

The Effect of Physical Activity on Perceived Fatigue in Relapsing-Remitting MS

Moderate-intensity interventions can help reduce perceived physical and cognitive fatigue in patients with relapsing-remitting multiple sclerosis.

Social cognition plays a key role in everyday lives of people with multiple sclerosis - Vimarsana News

Social cognition plays a key role in everyday lives of people with multiple sclerosis

. The authors are Helen M. Genova, PhD, of Kessler Foundation's Center for Neuropsychology and Neuroscience Research, and Stefano Ziccardi, PhD, Marco Pitteri, PhD, and Massimiliano Calabrese, MD, of the University of Verona. Dr. Genova also has an academic appointment at Rutgers University. Some recent MS research, including work led by Dr. Genova, has shown that social cognition deficits may affect people with MS who otherwise have no other cognitive impairments. Social cognition, which is required to understand and process the emotions of others, is an extremely important skill set for for...